I am a medical physicist working in the Department of Radiation Oncology at MSK’s regional facility in Basking Ridge, New Jersey. My work covers almost all aspects of physics support for the delivery of radiation therapy, including treatment planning for sophisticated external beam radiation therapy, which delivers optimal doses of radiation to the cancer target while sparing healthy tissue, and for image-guided radiosurgery, which uses imaging technologies to monitor the delivery of high-dose radiation treatments. I work extensively on our quality assurance program to ensure the safety and quality of our radiation treatments.
My research interests are broad and diverse. I am particularly interested in integrating advances in modern molecular biology with our understanding of how normal and cancerous tissues respond to radiation damage.
I am certified by the American Board of Radiology and licensed and registered in both New York State and New Jersey.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Jingdong Li discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.
View all disclosures